tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

XRTX Stock Latest News

XORTX Therapeutics Announces $3 Million Offering to Advance Gout Programs
Company AnnouncementsXORTX Therapeutics Announces $3 Million Offering to Advance Gout Programs
12d ago
6K
XRTX
Xortx Therapeutics prices 3.41M units at 88c in private placement
PremiumThe Fly
Xortx Therapeutics prices 3.41M units at 88c in private placement
12d ago
XRTX
XORTX Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
XORTX Therapeutics Reports Q1 2025 Financial Results
15d ago
6K
XRTX
XORTX Therapeutics Delays Yearly Report Filing
PremiumCompany Announcements
XORTX Therapeutics Delays Yearly Report Filing
30d ago
XRTX
XORTX Advances NDA Filing for Gout Treatment Following FDA Guidance
PremiumCompany Announcements
XORTX Advances NDA Filing for Gout Treatment Following FDA Guidance
1M ago
6K
XRTX
Xortx Therapeutics provides update on FDA Type B meeting request
PremiumThe FlyXortx Therapeutics provides update on FDA Type B meeting request
1M ago
XRTX
XORTX Secures European Patent for Gout and Kidney Disease Therapies
Premium
Company Announcements
XORTX Secures European Patent for Gout and Kidney Disease Therapies
1M ago
6K
XRTX
Xortx Therapeutics announces grant of European patent
Premium
The Fly
Xortx Therapeutics announces grant of European patent
1M ago
XRTX
XORTX Receives Nasdaq Notification for Minimum Bid Price Deficiency
PremiumCompany Announcements
XORTX Receives Nasdaq Notification for Minimum Bid Price Deficiency
1M ago
XRTX
Xortx Therapeutics discloses Nasdaq notification regarding minimum bid price
PremiumThe Fly
Xortx Therapeutics discloses Nasdaq notification regarding minimum bid price
1M ago
XRTX
XORTX Therapeutics Releases Annual Information Form for 2024
PremiumCompany Announcements
XORTX Therapeutics Releases Annual Information Form for 2024
2M ago
6K
XRTX
XORTX Therapeutics Faces Financial Challenges Amidst Operational Losses
PremiumCompany Announcements
XORTX Therapeutics Faces Financial Challenges Amidst Operational Losses
2M ago
6K
XRTX
XORTX Advances Gout Treatment Program with FDA Discussions
PremiumCompany AnnouncementsXORTX Advances Gout Treatment Program with FDA Discussions
2M ago
XRTX
Xortx Therapeutics to provide Type B meeting package to FDA during next week
Premium
The Fly
Xortx Therapeutics to provide Type B meeting package to FDA during next week
2M ago
XRTX
XORTX Advances Gout Treatment Program with FDA Meeting Request
Premium
Company Announcements
XORTX Advances Gout Treatment Program with FDA Meeting Request
3M ago
XRTX
Xortx Therapeutics commences gout program NDA discussions with FDA
PremiumThe Fly
Xortx Therapeutics commences gout program NDA discussions with FDA
3M ago
XRTX
XORTX Therapeutics Engages Investors at Microcap Conference
PremiumCompany Announcements
XORTX Therapeutics Engages Investors at Microcap Conference
4M ago
6K
XRTX
XORTX Announces Change of Auditor
PremiumCompany Announcements
XORTX Announces Change of Auditor
4M ago
6K
XRTX
XORTX Therapeutics Appoints New Auditor to Enhance Financial Oversight
PremiumCompany Announcements
XORTX Therapeutics Appoints New Auditor to Enhance Financial Oversight
4M ago
6K
XRTX
XORTX Therapeutics Announces Auditor Transition
PremiumCompany AnnouncementsXORTX Therapeutics Announces Auditor Transition
4M ago
XRTX
XORTX Therapeutics Expands Pipeline with Late-Stage Gout Program
Premium
Company Announcements
XORTX Therapeutics Expands Pipeline with Late-Stage Gout Program
5M ago
XRTX
Xortx Therapeutics announces launch of late stage program to treat gout
Premium
The Fly
Xortx Therapeutics announces launch of late stage program to treat gout
5M ago
XRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >